These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32773395)

  • 1. Targeted Therapies for Hereditary Peripheral Neuropathies: Systematic Review and Steps Towards a 'treatabolome'.
    Jennings MJ; Lochmüller A; Atalaia A; Horvath R
    J Neuromuscul Dis; 2021; 8(3):383-400. PubMed ID: 32773395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascorbic acid for the treatment of Charcot-Marie-Tooth disease.
    Gess B; Baets J; De Jonghe P; Reilly MM; Pareyson D; Young P
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011952. PubMed ID: 26662471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies.
    Vita G; Vita GL; Stancanelli C; Gentile L; Russo M; Mazzeo A
    Neurol Sci; 2019 Apr; 40(4):661-669. PubMed ID: 30847674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
    Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
    Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.
    Attarian S; Vallat JM; Magy L; Funalot B; Gonnaud PM; Lacour A; Péréon Y; Dubourg O; Pouget J; Micallef J; Franques J; Lefebvre MN; Ghorab K; Al-Moussawi M; Tiffreau V; Preudhomme M; Magot A; Leclair-Visonneau L; Stojkovic T; Bossi L; Lehert P; Gilbert W; Bertrand V; Mandel J; Milet A; Hajj R; Boudiaf L; Scart-Grès C; Nabirotchkin S; Guedj M; Chumakov I; Cohen D
    Orphanet J Rare Dis; 2014 Dec; 9():199. PubMed ID: 25519680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A.
    Attarian S; Young P; Brannagan TH; Adams D; Van Damme P; Thomas FP; Casanovas C; Kafaie J; Tard C; Walter MC; Péréon Y; Walk D; Stino A; de Visser M; Verhamme C; Amato A; Carter G; Magy L; Statland JM; Felice K
    Orphanet J Rare Dis; 2021 Oct; 16(1):433. PubMed ID: 34656144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update.
    Tazir M; Hamadouche T; Nouioua S; Mathis S; Vallat JM
    J Neurol Sci; 2014 Dec; 347(1-2):14-22. PubMed ID: 25454638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of Charcot-Marie-Tooth disease and related neuropathies.
    Pareyson D
    Neurol Sci; 2004 Jun; 25(2):72-82. PubMed ID: 15221625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pupil abnormalities in 131 cases of genetically defined inherited peripheral neuropathy.
    Houlden H; Reilly MM; Smith S
    Eye (Lond); 2009 Apr; 23(4):966-74. PubMed ID: 18636082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of hereditary neuropathies.
    Chance PF
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):277-91. PubMed ID: 11345007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological update: hereditary neuropathies.
    Kramarz C; Rossor AM
    J Neurol; 2022 Sep; 269(9):5187-5191. PubMed ID: 35596796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and new treatments in genetic neuropathies.
    Reilly MM; Shy ME
    J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1304-14. PubMed ID: 19917815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of hereditary neuropathies in adult-subjects].
    Pareyson D
    Minerva Med; 2003 Oct; 94(5):301-17. PubMed ID: 14973425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine inherited motor and sensory neuropathies: an updated classification in 22 breeds and comparison to Charcot-Marie-Tooth disease.
    Granger N
    Vet J; 2011 Jun; 188(3):274-85. PubMed ID: 20638305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current issues in hereditary neuropathies].
    Lacour A
    Rev Neurol (Paris); 2013 Dec; 169(12):1001-3. PubMed ID: 24230477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) rats.
    Prukop T; Wernick S; Boussicault L; Ewers D; Jäger K; Adam J; Winter L; Quintes S; Linhoff L; Barrantes-Freer A; Bartl M; Czesnik D; Zschüntzsch J; Schmidt J; Primas G; Laffaire J; Rinaudo P; Brureau A; Nabirotchkin S; Schwab MH; Nave KA; Hajj R; Cohen D; Sereda MW
    J Neurosci Res; 2020 Oct; 98(10):1933-1952. PubMed ID: 32588471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charcot‑Marie‑Tooth type 1A drug therapies: role of adenylyl cyclase activity and G‑protein coupled receptors in disease pathomechanism.
    Kiepura AJ; Kochański A
    Acta Neurobiol Exp (Wars); 2018; 78(3):198-209. PubMed ID: 30295677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of hereditary neuropathies in adult patients.
    Pareyson D
    J Neurol; 2003 Feb; 250(2):148-60. PubMed ID: 12574944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary sensory neuropathies.
    Houlden H; Blake J; Reilly MM
    Curr Opin Neurol; 2004 Oct; 17(5):569-77. PubMed ID: 15367861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.